Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

This meta-analysis examines the relationship between hormone replacement therapy (HRT), both estrogen alone and in combination with progestins, and the risk of breast cancer. The study found that current estrogen therapy use increases breast cancer risk (relative risk 1.40), with prolonged use (over 10 years) modestly raising the risk (relative